Metabolica Lifecare
Metabolica Lifecare is dedicated to providing the most advanced and innovative therapeutic solutions for metabolic and lifestyle diseases. They aim to collaborate globally with experts and organizations to develop and implement cutting-edge treatments, improving patient outcomes and quality of life.
Industries
Nr. of Employees
large (251-1000)
Products
MBX-O12
Collaborative therapeutic candidate developed with a Boston-based partner intended to manage dyslipidemia/hypercholesterolemia with an aim to avoid common statin-associated side effects.
MBX-311
Collaborative research project with a Nobel laureate researcher focused on interventions intended to delay or slow kidney damage and vascular calcification in patients with hypertension and diabetes.
MBX-711
Therapeutic candidate in collaboration with a California-based partner aimed at treating diabetic neuropathy while avoiding side effects commonly associated with gabapentinoids.
MBX-901
Collaborative project with a US research university targeting improvement of microangiopathy and cellular energy metabolism following ischemic events.
MBX-909
Collaborative project with a US-based partner aimed at improving clinical outcomes in diabetes and diabetic kidney disease.
MBX-O12
Collaborative therapeutic candidate developed with a Boston-based partner intended to manage dyslipidemia/hypercholesterolemia with an aim to avoid common statin-associated side effects.
MBX-311
Collaborative research project with a Nobel laureate researcher focused on interventions intended to delay or slow kidney damage and vascular calcification in patients with hypertension and diabetes.
MBX-711
Therapeutic candidate in collaboration with a California-based partner aimed at treating diabetic neuropathy while avoiding side effects commonly associated with gabapentinoids.
MBX-901
Collaborative project with a US research university targeting improvement of microangiopathy and cellular energy metabolism following ischemic events.
MBX-909
Collaborative project with a US-based partner aimed at improving clinical outcomes in diabetes and diabetic kidney disease.
Services
Arranging and managing collaborations with international companies, research universities, and individual researchers to co-develop or license therapeutic candidates.
Engaging cardio‑metabolic specialists to evaluate, advocate, or adopt externally developed therapeutic options within local clinical practice.
Sourcing advanced therapeutic solutions from international collaborators and supporting their introduction to the regional healthcare market.
Arranging and managing collaborations with international companies, research universities, and individual researchers to co-develop or license therapeutic candidates.
Engaging cardio‑metabolic specialists to evaluate, advocate, or adopt externally developed therapeutic options within local clinical practice.
Sourcing advanced therapeutic solutions from international collaborators and supporting their introduction to the regional healthcare market.
Expertise Areas
- Cardio‑metabolic and lifestyle disease therapeutics
- Collaborative therapeutic co‑development
- Translational research partnerships
- Clinical specialist engagement
Key Technologies
- Therapeutic candidate co‑development
- Translational and preclinical-to-clinical research
- Clinical collaboration networks
- Portfolio management for investigational therapeutics